Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 28084

1.

Hypoxic-Conditioned Medium from Adipose Tissue Mesenchymal Stem Cells Improved Neuroinflammation through Alternation of Toll like receptor (TLR) 2 and TLR4 Expression in Model of Alzheimer's Disease Rats.

Mehrabadi S, Motevaseli E, Sadr SS, Moradbeygi K.

Behav Brain Res. 2019 Nov 15:112362. doi: 10.1016/j.bbr.2019.112362. [Epub ahead of print]

PMID:
31739000
2.

Minocycline at 2 Different Dosages vs Placebo for Patients With Mild Alzheimer Disease: A Randomized Clinical Trial.

Howard R, Zubko O, Bradley R, Harper E, Pank L, O'Brien J, Fox C, Tabet N, Livingston G, Bentham P, McShane R, Burns A, Ritchie C, Reeves S, Lovestone S, Ballard C, Noble W, Nilforooshan R, Wilcock G, Gray R; Minocycline in Alzheimer Disease Efficacy (MADE) Trialist Group.

JAMA Neurol. 2019 Nov 18. doi: 10.1001/jamaneurol.2019.3762. [Epub ahead of print]

PMID:
31738372
3.

A Machine Learning Method for Identifying Critical Interactions Between Gene Pairs in Alzheimer's Disease Prediction.

Chen H, He Y, Ji J, Shi Y.

Front Neurol. 2019 Oct 31;10:1162. doi: 10.3389/fneur.2019.01162. eCollection 2019.

PMID:
31736866
4.

Patient and caregiver characteristics associated with caregiver burden in Parkinson's disease: a palliative care approach.

Macchi ZA, Koljack CE, Miyasaki JM, Katz M, Galifianakis N, Prizer LP, Sillau SH, Kluger BM.

Ann Palliat Med. 2019 Nov 14. pii: apm.2019.10.01. doi: 10.21037/apm.2019.10.01. [Epub ahead of print]

PMID:
31735048
5.

Therapeutic effects of Cyperus rotundus rhizome extract on memory impairment, neurogenesis and mitochondria in beta-amyloid rat model of Alzheimer's disease.

Shakerin Z, Esfandiari E, Ghanadian M, Razavi S, Alaei H, Dashti G.

Metab Brain Dis. 2019 Nov 16. doi: 10.1007/s11011-019-00493-2. [Epub ahead of print]

PMID:
31734846
6.

Alzheimer's disease tau is a prominent pathology in LRRK2 Parkinson's disease.

Henderson MX, Sengupta M, Trojanowski JQ, Lee VMY.

Acta Neuropathol Commun. 2019 Nov 16;7(1):183. doi: 10.1186/s40478-019-0836-x.

PMID:
31733655
7.

Detection of early-stage Alzheimer's pathology using blood-based autoantibody biomarkers in elderly hip fracture repair patients.

DeMarshall C, Oh E, Kheirkhah R, Sieber F, Zetterberg H, Blennow K, Nagele RG.

PLoS One. 2019 Nov 15;14(11):e0225178. doi: 10.1371/journal.pone.0225178. eCollection 2019.

PMID:
31730624
8.

Vildagliptin Attenuates Huntington's Disease through Activation of GLP-1 Receptor/PI3K/Akt/BDNF Pathway in 3-Nitropropionic Acid Rat Model.

Sayed NH, Fathy N, Kortam MA, Rabie MA, Mohamed AF, Kamel AS.

Neurotherapeutics. 2019 Nov 14. doi: 10.1007/s13311-019-00805-5. [Epub ahead of print]

PMID:
31728850
9.

Multi-atlas label fusion with random local binary pattern features: Application to hippocampus segmentation.

Zhu H, Tang Z, Cheng H, Wu Y, Fan Y.

Sci Rep. 2019 Nov 14;9(1):16839. doi: 10.1038/s41598-019-53387-9.

PMID:
31727982
10.

Vitamin D deficiency as a risk factor for dementia and Alzheimer's disease: an updated meta-analysis.

Chai B, Gao F, Wu R, Dong T, Gu C, Lin Q, Zhang Y.

BMC Neurol. 2019 Nov 13;19(1):284. doi: 10.1186/s12883-019-1500-6.

11.

The TOMMORROW study: Design of an Alzheimer's disease delay-of-onset clinical trial.

Burns DK, Chiang C, Welsh-Bohmer KA, Brannan SK, Culp M, O'Neil J, Runyan G, Harrigan P, Plassman BL, Lutz M, Lai E, Haneline S, Yarnall D, Yarbrough D, Metz C, Ponduru S, Sundseth S, Saunders AM.

Alzheimers Dement (N Y). 2019 Oct 28;5:661-670. doi: 10.1016/j.trci.2019.09.010. eCollection 2019.

12.

Lipid lowering and Alzheimer's disease risk: a Mendelian randomization study.

Williams DM, Finan C, Schmidt AF, Burgess S, Hingorani AD.

Ann Neurol. 2019 Nov 12. doi: 10.1002/ana.25642. [Epub ahead of print]

PMID:
31714636
13.

Cerebrolysin for vascular dementia.

Cui S, Chen N, Yang M, Guo J, Zhou M, Zhu C, He L.

Cochrane Database Syst Rev. 2019 Nov 11;2019(11). doi: 10.1002/14651858.CD008900.pub3. Review.

PMID:
31710397
14.

Reactions to Multiple Ascending Doses of the Microtubule Stabilizer TPI-287 in Patients With Alzheimer Disease, Progressive Supranuclear Palsy, and Corticobasal Syndrome: A Randomized Clinical Trial.

Tsai RM, Miller Z, Koestler M, Rojas JC, Ljubenkov PA, Rosen HJ, Rabinovici GD, Fagan AM, Cobigo Y, Brown JA, Jung JI, Hare E, Geldmacher DS, Natelson-Love M, McKinley EC, Luong PN, Chuu EL, Powers R, Mumford P, Wolf A, Wang P, Shamloo M, Miller BL, Roberson ED, Boxer AL.

JAMA Neurol. 2019 Nov 11. doi: 10.1001/jamaneurol.2019.3812. [Epub ahead of print]

PMID:
31710340
15.

Integrate GWAS, eQTL, and mQTL Data to Identify Alzheimer's Disease-Related Genes.

Zhao T, Hu Y, Zang T, Wang Y.

Front Genet. 2019 Oct 25;10:1021. doi: 10.3389/fgene.2019.01021. eCollection 2019.

16.

Efficacy and Safety of Brexpiprazole for the Treatment of Agitation in Alzheimer's Dementia: Two 12-Week, Randomized, Double-Blind, Placebo-Controlled Trials.

Grossberg GT, Kohegyi E, Mergel V, Josiassen MK, Meulien D, Hobart M, Slomkowski M, Baker RA, McQuade RD, Cummings JL.

Am J Geriatr Psychiatry. 2019 Oct 1. pii: S1064-7481(19)30521-4. doi: 10.1016/j.jagp.2019.09.009. [Epub ahead of print]

PMID:
31708380
17.

Antihypertensive medications and risk for incident dementia and Alzheimer's disease: a meta-analysis of individual participant data from prospective cohort studies.

Ding J, Davis-Plourde KL, Sedaghat S, Tully PJ, Wang W, Phillips C, Pase MP, Himali JJ, Gwen Windham B, Griswold M, Gottesman R, Mosley TH, White L, Gu├░nason V, Debette S, Beiser AS, Seshadri S, Ikram MA, Meirelles O, Tzourio C, Launer LJ.

Lancet Neurol. 2019 Nov 6. pii: S1474-4422(19)30393-X. doi: 10.1016/S1474-4422(19)30393-X. [Epub ahead of print]

PMID:
31706889
18.

ANAVEX®2-73 (blarcamesine), a Sigma-1 receptor agonist, ameliorates neurologic impairments in a mouse model of Rett syndrome.

Kaufmann WE, Sprouse J, Rebowe N, Hanania T, Klamer D, Missling CU.

Pharmacol Biochem Behav. 2019 Dec;187:172796. doi: 10.1016/j.pbb.2019.172796. Epub 2019 Nov 5.

PMID:
31704481
19.

CAN MILD COGNITIVE IMPAIRMENT BE STABILIZED BY SHOWERING BRAIN MITOCHONDRIA WITH LASER PHOTONS?

de la Torre JC, Olmo AD, Valles S.

Neuropharmacology. 2019 Nov 5:107841. doi: 10.1016/j.neuropharm.2019.107841. [Epub ahead of print] Review.

PMID:
31704275
20.

Promoting independence in Lewy body dementia through exercise (PRIDE) study: Protocol for a pilot study.

Inskip M, Mavros Y, Sachdev PS, Fiatarone Singh MA.

Contemp Clin Trials Commun. 2019 Oct 12;16:100466. doi: 10.1016/j.conctc.2019.100466. eCollection 2019 Dec.

Supplemental Content

Loading ...
Support Center